Effect of Recombinant Human Interferons in Inducing Differentiation of Acute Megakaryoblastic Leukaemia Blast Cells

References

• Eguchi M., Ozawa T., Sakakibara H., Sugita K., Iwama Y., Furukawa T. Ultrastructural and ultracyto-chemical differences between megakaryoblastic leukemia in children and adults. Analysis of 49 patients. Cancer 1992; 70: 451–458
   PubMed Web of Science ®Google Scholar
• Hassan H. T. Synergism between differentiation agents: preclinical and clinical studies in myeloid leukemia. The pharmacology of cell differentiation, R. A. Rifkind. Elsevier, Amsterdam 1993; 277–294
   Google Scholar
• Tsuda H., Sakaguchi M., Kawakita M., Nakazawa S., Mori T., Takatsuki K. Alteration of cell cycle progression in human leukemia cell line (KOPM-28) induced by 12-o-tetradecanoylphorbol-13-acetate. Int. J. Cell Clon. 1988; 6: 209–220
   PubMedGoogle Scholar
• Ogura M., Morishima Y., Okumura M., Hotta T., Ohno S., Takamoto R., Hirabayashi N., Nagura H., Saito H. Functional and morphological differentiation induction of a human megakaryoblastic leukemia cell line (MEG-01s) by phorbol diesters. Blood 1988; 72: 49–60
   PubMed Web of Science ®Google Scholar
• Tange T., Nakahara K., Mitani K., Yamasaki I., Yasuda H., Tanaka F., Mizuguchi M., Oda H., Yatomi Y., Takanashi R., Fujioka S., Yamaguchi K., Urano Y. Establishment of a human megakaryoblastic cell line (T-33) from chronic myelogenous leukemia in megakaryoblastic crisis. Cancer Res 1988; 48: 6137–6144
   PubMed Web of Science ®Google Scholar
• Greenberg S. M., Rosenthal D. S., Greeley T. A., Tantravahi R., Handin R. I. Characterization of a new megakaryocytic cell line: The Dami cell. Blood 1988; 72: 1968–1977
   PubMed Web of Science ®Google Scholar
• Komatsu N., Nakauchi H., Miwa A., Ishihara T., Eguchi M., Moroi M., Okada M., Sato Y., Wada H., Yawata Y., et al. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. Cancer Res. 1991; 51: 341–348
   PubMed Web of Science ®Google Scholar
• Morgan D. A., Gumucio D. L., Brodsky I. Granulocyte-macrophage colony-stimulating factor-dependent growth and erythropoietin-induced differentiation of a human cell line MB-02. Blood 1991; 78: 2860–2871
   PubMed Web of Science ®Google Scholar
• Komatsu N., Suda T., Moroi M., Tokuyama N., Sakata Y., Okada M., Nishida T., Hirai Y., Sato T., Fuse A., Miura Y. Growth and differentiation of a human megakaryoblastic cell line. CMK. Blood 1989; 74: 42–48
   PubMed Web of Science ®Google Scholar
• Yumura Yagi K., Hara J., Kurahashi H., Nishiura T., Kaneyama Y., Osugi Y., Sakata N., Inoue M., Tawa A., Okada S., Kawa-Ha K. Mixed phenotype of blasts in acute megakaryocyte leukaemia and transient abnormal myelopoiesis in Down's syndrome. Br. J. Haematol 1992; 81: 520–525
   PubMed Web of Science ®Google Scholar
• Imamura N., Mtasiwa D. M., Inada T., Kuramoto A., Ogura M., Saito H. Synergistic effect of recombinant human erythropoeitin and phorbol diester in platelet production by the human megakaryoblastic leukemia cell line (MEG-01) [letter]. Am. J. Hematol. 1990; 34: 77–79
   PubMed Web of Science ®Google Scholar
• Murate T., Hotta T., Tsushita K., Suzuki M., Yoshida T., Saga S., Saito H., Yoshida S. Aphidicolin, an inhibitor of DNA replication, blocks the TPA-induced differentiation of a human megakaryoblastic cell line, MEG-01. Blood 1991; 78: 3168–3177
   PubMed Web of Science ®Google Scholar
• Song L. N., Cheng T. Effects of 1,25-dihydroxy-vitamin D3 analogue l,24(OH)2 22-ene-24-cyclopropyl D3 on proliferation and differentiation of a human megakaryoblastic leukemia cell line. Biochem. Pharmacol. 1992; 43: 2292–2295
   PubMed Web of Science ®Google Scholar
• Dorn G. W., Davis M. G. Thrombin, but not thromboxane, stimulates megakaryocyte differentiation in human megakaryoblastic leukemia cells. J. Pharmacol. Exp. Ther. 1992; 262: 1242–1247
   PubMed Web of Science ®Google Scholar
• Ishibashi T., Kimura H., Uchida T., Kariyone S., Friese P., Burstein S. A. Human interleukin-6 is a direct promoter of maturation of megakaryocytes in vitro. Proc. Natl. Acad. Sci. USA 1989; 86: 5953–5957
   PubMed Web of Science ®Google Scholar
• Zeidler C., Kanz L., Hurkuck F., Souza L., Welte K. In vivo effects of interleukin-6 and leukaemia inhibitory factor on thrombopoiesis in primates. Cytokines in hemopoiesis, oncology and AIDS I, M. Freund, H. Link, R. E. Schmidt, K. Welte. Springer Verlag, Berlin 1992; 411–416
   Google Scholar
• Fuse A., Kakuda H., Shima Y., Van Damme J., Billiau A., Sato T. Interleukin-6, a possible autocrine growth and differentiation factor for the human megakaryo-cytic cell line. CMK. Br. J. Haematol 1991; 77: 32–36
   PubMed Web of Science ®Google Scholar
• Brach M. A., Lowenberg B., Mantovani L., Schwulera U., Mertelsmann R., Herrmann F. Interleukin-6 (IL-6) is an intermediate in IL-1-induced proliferation of leukemic human megakaryoblasts. Blood 1990; 76: 1972–1979
   PubMed Web of Science ®Google Scholar
• Miyauchi J., Sugita K., Okui J., Taguchi N., Clark S. C., Shimizu K. Differentiation induction of blast cells in two cases of childhood acute megakaryoblastic leukemia in vitro by interleukin-3 and interleukin-6: an ultra-structural cytochemical study. J. Cell. Physiol. 1991; 148: 404–413
   PubMed Web of Science ®Google Scholar
• Hoffman R., Briddell R. A., Straneva J. E., Bruno J. E., Brandt E., Ganser A., Hudson N., Guscar T. Cytokine control of human megakaryocytopoiesis. Prog. Clin. Biol. Res. 1990; 338: 75–103
   PubMedGoogle Scholar
• Hassan H. T., Rees J. K. Triple combination of retinoic acid + low concentration of cytosine arabinoside + hexamethylene bisacetamide induces differentiation of human AML blasts in primary culture. Hematol. Oncol. 1989; 7: 429–440
   PubMed Web of Science ®Google Scholar
• Mason D. Y. Immunocytochemical labelling of monoclonal antibodies by the APAAP immunoalkaline phosphatase technique. Techniques in immunochestry, G. R. Bulock, P. Petrusz. Academic Press, Oxford 1985; 25–40
   Google Scholar
• Han Z. C., Bellucci S., Tenza D., Caen J. P. Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and beta thromboglobulin: comparative analysis in bone marrow cultures from normal individuals and patients with essential thrombocythaemia and immune thrombocytopenic purpura. Br. J. Haematol 1990; 41: 395–401
   Web of Science ®Google Scholar
• Han Z. C., Bellucci S., Caen J. P. Megakaryocytopoiesis: characterization and regulation in normal and pathologic states. Int. J. Hematol. 1991; 54: 3–14
   PubMed Web of Science ®Google Scholar
• Han Z. C., Bellucci S., Wan H. Y., Caen J. P. New insights into the regulation of megakaryocytopoiesis by haematopoietic and fibroblastic growth factors and transforming growth factor beta 1. Br. J. Haematol. 1992; 81: 1–5
   PubMed Web of Science ®Google Scholar
• Sonoda Y., Kuzuyama Y., Tanaka S., Yokota S., Mae-Kawa T., Clark S. C., Abe T. Human interleu-kin-4 inhibits proliferation of megakaryocyte progenitor cells in culture. Blood 1993; 81: 624–630
   PubMed Web of Science ®Google Scholar
• Hassan H. T., Maurer H. R. Effects of recombinant human cytokines on cytarabine activity in K562 human myeloid leukaemia cells. Cytokines in hemopoiesis, oncology and AIDS II, M. Freund, H. Link, R. E. Schmidt, K. Welte. Springer Verlag, Berlin 1992; 313–319
   Google Scholar
• Sawyers C. L., Denny C. T., Witte O. N. Leukemia and the disruption of normal hematopoiesis. Cell 1991; 64: 337–350
   PubMed Web of Science ®Google Scholar
• Hassan H. T., Maurer H. R. Preclinical screening of in vivo interactions between myelopoietic growth factors and natitumour drugs for therapy of myeloid leukaemia patients (review). In Vivo 1991; 5: 337–350
   Google Scholar
• Hassan H. T., Zyada L. E. Treatment with recombinant human interferon-alpha plus low-dose cytarabine with or without hydroxyurea for acute monoblastic leukemia. Hematol. Rev. Commun. 1993; 7: 125–131
   Google Scholar
• Koike T., Urushiyama M., Narita M., Saitoh H., Ishida F., Imashuku S., Morioka Y., Utsumi J., Ishizuka T., Tsuruta T., Takouchi Y., Kashimura M., Shibata A. Target cell of leukemic transformation in acute megakaryoblastic leukemia. Am. J. Hematol. 1990; 34: 252–258
   PubMed Web of Science ®Google Scholar
• Cuneo A., Mecucci C., Vandenberghe S., Kerim E., Dal Cin P., Van Orshoven A., Rodhain J., Bosly A., Michaux J.-L., Martiat P., Boogaerts M., Carli M. G., Castoldi G., Van den Berghe H. Multipotent stem cell involvement in megakaryoblastic leukemia: Cytologic and cytogenetic evidence in 15 patients. Blood 1989; 74: 1781–1790
   PubMed Web of Science ®Google Scholar